Skip to main content

Table 1 Clinical and laboratory characteristics of patients with aSAH and healthy controls

From: Polymorphism and plasma levels of apolipoprotein E and the risk of aneurysmal subarachnoid hemorrhage in a Chinese population: a case-control study

 

aSAH(n = 131)

Controls(n = 137)

P value

Age (years)

54.65 ± 13.53

55.23 ± 10.44

0.688

Sex-No (male %)

41.98(55/131)

41.61(57/137)

0.928

BMI (kg/m2)

24.84 ± 3.79

24.16 ± 3.39

0.744

Smoking (%)

26.43(37/131)

23.36(32/137)

0.581

Drinking (%)

15.27(20/131)

18.98(26/137)

0.421

Hypertension (%)

43.51(57/131)

38.69(53/137)

0.422

TC (m mol/L)

4.52 ± 1.38

5.11 ± 0.86

< 0.001*

TG (m mol/L)

1.23 ± 0.77

1.29 ± 0.75

0.566

HDL-C (m mol/L)

1.23 ± 0.46

1.44 ± 0.32

< 0.001*

LDL-C (m mol/L)

3.19 ± 1.47

3.27 ± 0.82

0.625

ApoA1 (g/L)

1.20 ± 0.32

1.38 ± 0.25

< 0.001*

ApoB (g/L)

0.93 ± 0.31

0.99 ± 0.21

0.075

  1. Data are expressed as the means ± standard deviation, except for sex, smoking, drinking and hypertension which is expressed as the number (%). TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, ApoA1 Apolipoproteina1, ApoB Apolipoprotein B
  2. P value, 2-sample independent t-test, or chi-squared test as appropriate. *P < 0.001, compared with controls
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X